|
Title:
|
3. Discussion with possible action to consider the cost benefit analysis of including anti-obesity medications (AOM) approved by the United States of America (USA) Food and Drug Administration (FDA) in the City of Laredo employees’ health insurance benefits package, and any other matters incident thereto.
|